Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

NCT00955357 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

461

Enrollment

INDUSTRY

Sponsor class

Conditions

Partial Epilepsies

Interventions

DRUG: Lacosamide

Sponsor

UCB Pharma